GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Impact BioMedical Inc
Impact BioMedical's value as an early-stage biotech company is determined by the potential of its scientific developments. Its valuation in the private market depends on preclinical data and its ability to attract venture capital funding for further research.
Share prices of companies in the market segment - Pharma other
Impact BioMedical is a biopharmaceutical company developing a wide range of drugs for the treatment of various diseases. We classified it in "Other Pharma" due to its diversified approach. The chart below reflects general trends and risks in the biotech sector.
Broad Market Index - GURU.Markets
Impact BioMedical is a biopharmaceutical company developing drugs to treat cancer and other diseases. Its scientific research makes it a prominent player in the GURU.Markets index. The chart below represents the entire market. Find out how Impact BioMedical compares to it.
Change in the price of a company, segment, and market as a whole per day
IBO - Daily change in the company's share price Impact BioMedical Inc
For Impact BioMedical Inc., a pharmaceutical company, daily volatility reflects sensitivity to scientific data and progress in the development of its drugs. This metric is an important element in formulas assessing risks in biotech.
Daily change in the price of a set of shares in a market segment - Pharma other
IBio, Inc. (IBO) uses the innovative FastPharming plant-based platform to rapidly develop and manufacture vaccines and therapeutic proteins. The company operates in the competitive biopharmaceutical manufacturing market. The chart below shows the average volatility in this sector, allowing you to compare how IBO's stock performance compares to the overall industry trends.
Daily change in the price of a broad market stock, index - GURU.Markets
Impact BioMedical is a pharmaceutical company developing new drugs. Its shares, like many in the sector, are volatile and react to news about clinical trials. These science-driven movements are part of the overall stock market landscape.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Impact BioMedical Inc
Impact BioMedical Inc.'s growth is a story of developing innovative treatments. Its 12-month market capitalization is entirely dependent on progress in preclinical and clinical trials. Every successful step confirms the potential of its scientific platform and brings the development of new, more effective drugs closer.
Annual dynamics of market capitalization of the market segment - Pharma other
Impact, as an early-stage biotech company, is a high-risk bet on science. Its performance is completely disconnected from the sector and depends on news about clinical trials. Its stock price will reflect investors' speculative belief in the potential of its unique developments.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Impact BioMedical is committed to developing universal antiviral drugs, which is especially relevant in the post-pandemic world. Its year-over-year market capitalization reflects the extent to which investors believe in the possibility of creating "one pill for many viruses." This is an ambitious goal, and any progress in this direction is attracting significant attention.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Impact BioMedical Inc
Impact BioMedical is a pharmaceutical company. Its monthly price movement is typical for the sector: it depends on progress in its scientific research and clinical programs. News of trial results or funding raises are the main drivers of its value.
Monthly dynamics of market capitalization of the market segment - Pharma other
Impact BioMedical is a pharmaceutical development company. Its success, like many early-stage biotechs, depends on scientific breakthroughs, preclinical and clinical data, and the ability to attract funding. The pharmaceutical sector chart will provide an overview of the overall investment climate in the industry, which is important for assessing Impact's prospects.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Impact BioMedical is an early-stage company whose operations and prospects are not fully understood. Shares of such companies are highly speculative, and their performance is unpredictable. This is determined not by market trends, but by corporate announcements and the company's ability to raise funding for its projects.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Impact BioMedical Inc
Impact BioMedical, as an early-stage biopharmaceutical company, is a highly speculative asset. Its weekly stock price reflects not financial reports, but rather news about preclinical studies, patents, and investor confidence in the company's underlying scientific concept.
Weekly dynamics of market capitalization of the market segment - Pharma other
Impact BioMedical is in the early stages of developing antiviral and oncology drugs. Shares of such companies often move not with the market, but in anticipation of breakthrough scientific results. This chart clearly demonstrates how the company's performance differs from the industry average.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Impact BioMedical is an early-stage biotech company. Its shares represent a venture-backed bet on science and can exhibit extreme volatility on news releases. The chart clearly demonstrates how its weekly performance can be out of sync with overall market movements.
Market capitalization of the company, segment and market as a whole
IBO - Market capitalization of the company Impact BioMedical Inc
Impact BioMedical's market capitalization represents investors' bets on its pharmaceutical developments. Its dynamics will reflect the progress of its research and the potential of its drugs to treat various diseases. Its extremely small scale and high volatility are typical for early-stage biotech companies.
IBO - Share of the company's market capitalization Impact BioMedical Inc within the market segment - Pharma other
Impact BioMedical is an early-stage biopharmaceutical company. Its market share in the sector is near zero, which is typical for such companies. Its market cap is purely speculative, based on its scientific ideas, intellectual property, and potential for developing new treatments.
Market capitalization of the market segment - Pharma other
This chart shows the overall market capitalization of the entire pharmaceutical sector. For Impact BioMedical, a small biotech company working on specialized drugs, this line represents the scale of the ocean in which it operates. The chart's fluctuations reflect global investor sentiment toward the entire industry, against which the company is trying to prove the value of its developments.
Market capitalization of all companies included in a broad market index - GURU.Markets
Impact BioMedical is an early-stage company developing new therapeutic approaches. Its market capitalization is essentially a valuation of its ideas and team. It's a speculative share, representing investors' faith in a future scientific breakthrough.
Book value capitalization of the company, segment and market as a whole
IBO - Book value capitalization of the company Impact BioMedical Inc
Impact BioMedical is a biotechnology company, and its book value is its scientific and financial capital. This capital consists of laboratories, research equipment, and the cash that enables the company to conduct its research. How has this scientific budget changed over time? The chart below shows this story.
IBO - Share of the company's book capitalization Impact BioMedical Inc within the market segment - Pharma other
Impact BioMedical Inc. is a biotechnology company whose research requires a physical base. The company's balance sheet reflects the value of its laboratories, equipped with equipment for conducting research and development. The chart shows the company's share of the physical R&D infrastructure in this innovative sector.
Market segment balance sheet capitalization - Pharma other
Impact BioMedical is likely a biotech company. Pharmaceuticals, as the graph shows, are knowledge- and capital-intensive. Its capital is intellectual property and R&D infrastructure for clinical trials.
Book value of all companies included in the broad market index - GURU.Markets
Impact BioMedical's assets are not factories, but a portfolio of patents and preclinical developments in antiviral and anticancer drugs. The book value reflects the estimated value of this intellectual property and the capital available for its further development. The chart illustrates the scale of this R&D startup.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Impact BioMedical Inc
Impact BioMedical is a biopharmaceutical company. Its market valuation reflects its pipeline and investors' confidence in its ability to bring them to market. This is a classic biotech story, where future potential is valued far more than current assets.
Market to book capitalization ratio in a market segment - Pharma other
Impact BioMedical is a pharmaceutical development company. Its high valuation on this chart reflects investors' faith in its scientific pipeline and its ability to bring at least one of its drugs to market, despite the long and expensive development process.
Market to book capitalization ratio for the market as a whole
Impact BioMedical is an early-stage company working on breakthrough medical technologies. Its valuation is based on pure expectations of future success, as it may have few tangible assets. This chart demonstrates how significantly the market valuation of such "idea companies" can deviate from their book value in the broader market.
Debts of the company, segment and market as a whole
IBO - Company debts Impact BioMedical Inc
Impact BioMedical, an early-stage company, is raising capital to fund its preclinical research. At this stage, traditional debt is unlikely, and funding comes from venture capitalists. This chart reflects the initial, riskiest stage in a biotech company's life, when all funds are invested in research.
Market segment debts - Pharma other
Impact BioMedical is an early-stage pharmaceutical development company. For these companies, capital is vital for conducting preclinical studies and testing scientific hypotheses. This chart illustrates the startup's financial model, which relies entirely on external funding to advance its innovative, yet high-risk, ideas.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Impact BioMedical Inc
Impact BioMedical is developing new therapeutic approaches. Like most early-stage biotech companies, its operations are entirely dependent on its ability to raise capital for research. This chart shows the company's use of debt, which is an indicator of its financial risk before any revenue is generated.
Market segment debt to market segment book capitalization - Pharma other
Impact BioMedical, as its name suggests, is an early-stage biomedical company. These companies rely entirely on external funding to conduct research. This chart shows its debt structure, which is a key element of its financial viability, compared to other biotech companies.
Debt to book value of all companies in the market
Impact BioMedical develops drugs to treat a variety of diseases, including viral infections and cancer. Early-stage biotech companies are often entirely dependent on external financing. What role does debt play in their survival strategy? This graph of total debt in the economy helps assess the risks associated with funding such innovative but uncertain projects.
P/E of the company, segment and market as a whole
P/E - Impact BioMedical Inc
Impact BioMedical is a biopharmaceutical solutions company. This chart reflects speculative investor interest in its research and development. The valuation is not always based on current financial performance, but rather on expectations for potential scientific breakthroughs.
P/E of the market segment - Pharma other
Impact BioMedical Inc. is a biomedical company focused on developing innovative healthcare solutions. Its focus determines its market position. This chart shows the average valuation in the pharmaceutical sector, allowing you to compare the company to peers working on new treatments.
P/E of the market as a whole
Impact BioMedical Inc. is a biomedical company that may be developing various therapeutic or diagnostic products. This chart reflects investors' overall risk appetite. It helps understand whether IBO's valuation reflects speculative interest in its developments or follows broader trends in the healthcare sector.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Impact BioMedical Inc
Impact BioMedical is an early-stage biopharmaceutical company developing drugs across various therapeutic areas. Like many biotech companies, its value is based almost entirely on future potential. This chart shows how investors evaluate the scientific prospects of its developments, factoring their expectations for future success into the price.
%20P%2FE%20Impact%20BioMedical%20Inc&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Impact-BioMedical-Inc&v=1772587108209 "Chart of the company's future (projected) P/E Impact BioMedical Inc")
Future (projected) P/E of the market segment - Pharma other
Impact BioMedical is developing new therapeutics. Like many early-stage biotech companies, its valuation is based on future potential. The chart shows speculative profitability forecasts for the sector. It allows for a comparison of how the market values Impact BioMedical's scientific ideas compared to others.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-other&v=1772587108228 "Future (projected) P/E graph of the market segment - Pharma other")
Future (projected) P/E of the market as a whole
Impact BioMedical Inc. is in the early stages of therapeutic development. The valuation of such companies is based almost entirely on faith in their scientific potential. This overall risk appetite curve is critically important, as it determines the availability of capital to fund fundamental research and early clinical trials.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772587108282 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Impact BioMedical Inc
Impact BioMedical Inc. is likely an early-stage biotech company developing drugs to treat serious diseases. Its financial metrics in this chart likely reflect initial investments in research and development, which are the foundation for future growth and potential profitability.
Profit of companies in the market segment - Pharma other
Impact BioMedical Inc. is likely a biotech company focused on creating a significant impact on disease treatment through innovative developments. Such companies often operate in cutting-edge scientific fields. This chart illustrates the overall picture in the pharmaceutical sector, where the potential for breakthrough drugs determines company valuations, even in the early stages.
Overall market profit
Impact BioMedical Inc. is a biomedical company whose prospects, like most companies in this sector, are determined by the success of its research and development. Its activities are not tied to the general economic cycles reflected in this chart. The company's value depends on the potential of its scientific discoveries, not on the current state of its corporate profits.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Impact BioMedical Inc
Impact BioMedical is an early-stage company likely developing novel therapeutic approaches. Its future revenue is purely hypothetical and depends on the successful validation of its scientific concepts. This chart represents a highly speculative estimate of the company's potential based on early data and the prospects of its research platform.
%20profit%20of%20the%20company%20Impact%20BioMedical%20Inc&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Impact-BioMedical-Inc&v=1772587108355 "Graph of future (projected) profit of the company Impact BioMedical Inc")
Future (predicted) profit of companies in the market segment - Pharma other
Impact BioMedical is a biopharmaceutical company developing new therapeutics to address various medical challenges. Its future depends on the success of its research programs and the advancement of its clinical developments. This chart shows profitability expectations for the pharmaceutical sector, providing context for the company's valuation.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-other&v=1772587108374 "Graph of future (predicted) profits of companies in a market segment - Pharma other")
Future (predicted) profit of the market as a whole
Impact BioMedical Inc. is a biomedical company, likely in the early stages of development. Its survival and growth are entirely dependent on raising research funding. This earnings forecast chart reflects the general sentiment of investors and their willingness to invest in high-risk but potentially breakthrough scientific projects.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772587108475 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Impact BioMedical Inc
Impact BioMedical is an early-stage biopharmaceutical company. Revenue is likely nonexistent at this stage. This chart is purely speculative, reflecting investor sentiment about the company's scientific concepts and potential for future products, not its current operations.
P/S market segment - Pharma other
Impact BioMedical is a biotech company at the forefront of medical research, developing new therapeutic approaches to treat serious diseases. The success of these companies depends on clinical trial results and scientific breakthroughs. This chart reflects the average revenue estimate for the sector, reflecting the high risks and potential rewards.
P/S of the market as a whole
Impact BioMedical is a company developing therapeutic solutions across various medical fields. For early-stage companies, this chart, which displays average revenue estimates, serves as a reminder that their valuation is based not on cash flow, but on faith in scientific potential and future breakthroughs.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Impact BioMedical Inc
Impact BioMedical, as its name suggests, is a biomedical company, likely in the early stages of development. A valuation based on future revenues for such a company is hypothetical, but crucial. It reflects investors' faith in its scientific concept, whether a new therapy or diagnostic tool, and its long-term potential for commercialization and value creation.
%20P%2FS%20Impact%20BioMedical%20Inc&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Impact-BioMedical-Inc&v=1772587108652 "The graph of the company's future (projected) P/S Impact BioMedical Inc")
Future (projected) P/S of the market segment - Pharma other
Impact BioMedical is a company focused on research and development of new therapeutic approaches. This chart reflects how investors assess the company's future revenues relative to the broader biotech sector. The valuation at this stage is heavily dependent on the market's confidence in the scientific merits of its early developments and their potential for further development into full-fledged drugs.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-other&v=1772587108747 "Future (projected) P/S market segment graph - Pharma other")
Future (projected) P/S of the market as a whole
Impact BioMedical is developing a portfolio of therapeutics aimed at addressing various medical challenges. As an early-stage company, its future depends on funding and the success of preclinical studies. This market forecast chart reflects investor appetite for high-risk biotech startups with breakthrough potential.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772587108758 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Impact BioMedical Inc
This chart shows the revenue of Impact BioMedical, a biotechnology research and development company. Commercial revenue from product sales is likely absent. Funding flows reflected here may be related to grants, partnership payments, or other sources of R&D funding.
Sales of companies in the market segment - Pharma other
Impact BioMedical Inc. is a biopharmaceutical company developing drugs to treat a variety of diseases. Its revenue structure, as it develops, will determine which of its research projects—whether in oncology or antiviral therapy—will be the first to reach the commercial stage.
Overall market sales
Impact BioMedical Inc. is a biomedical company focused on developing solutions for various diseases. Its success, like that of many biotech companies, depends on scientific breakthroughs and clinical trials. This overall economic activity chart serves only as a backdrop for an industry that operates by its own laws of discovery and regulatory approval.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Impact BioMedical Inc
Impact BioMedical Inc. is a research and development biopharmaceutical company focused on developing new treatments for various diseases. The company does not currently have any commercial products. This chart illustrates analysts' long-term revenue expectations for the company's successful commercialization in the future.
%20sales%20of%20the%20company%20Impact%20BioMedical%20Inc&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Impact-BioMedical-Inc&v=1772587108915 "Schedule of future (projected) sales of the company Impact BioMedical Inc")
Future (projected) sales of companies in the market segment - Pharma other
Impact BioMedical Inc. develops pharmaceuticals. This chart shows sales forecasts for the entire biotech sector. Is the market expected to grow thanks to new discoveries and drug approvals, or will the industry face pricing pressure? This provides an overview of the company's operating environment.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-other&v=1772587108926 "Schedule of future (projected) sales of companies in the market segment - Pharma other")
Future (projected) sales of the market as a whole
Impact BioMedical is an early-stage biomedical company. Its activities are likely focused on developing new therapeutic approaches. Like most biotech companies at this stage, its valuation is determined by scientific potential, not economic trends. This graph does not reflect the fundamental scientific processes underlying its operations.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772587108958 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Impact BioMedical Inc
Impact BioMedical Inc. is a biopharmaceutical company developing new treatments for various diseases. This chart reflects its financial performance at an early stage of development. Profitability is a long-term prospect and depends entirely on the success of its research, preclinical, and clinical trials, which require significant funding.
Market segment marginality - Pharma other
Impact BioMedical Inc. is a biomedical company developing therapeutic solutions. Its financial performance reflects the research and development phase, where the primary expense items are scientific research and clinical trials. For such companies, profitability is a future goal, dependent on the successful commercialization of their discoveries.
Market marginality as a whole
Impact BioMedical, as its name suggests, is a biotech company seeking to make a significant impact on medicine. Its success depends on scientific breakthroughs and its ability to attract capital. This total return chart reflects the investment environment, which, during growth periods, is more favorable to risky but potentially revolutionary projects.
Employees in the company, segment and market as a whole
Number of employees in the company Impact BioMedical Inc
Impact BioMedical is an early-stage company developing therapeutic solutions. At such startups, the team often consists of several founders and key scientists. This graph shows a very small team, and any growth would represent a significant step forward, such as raising funding or starting preclinical trials.
Share of the company's employees Impact BioMedical Inc within the market segment - Pharma other
Impact BioMedical is an early-stage company focused on research and development of new therapeutic approaches. Like many biotech startups, its staff is small and consists of a core scientific team. This graph shows its labor market share, and its minimum value reflects its R&D-driven model, which emphasizes science over scale.
Number of employees in the market segment - Pharma other
Impact BioMedical Inc. is a biopharmaceutical company working on a wide range of therapeutic solutions. The chart reflects overall employment in the pharmaceutical industry. The company's diversified approach allows it to explore various areas, from antiviral to anticancer drugs, in search of breakthrough technologies.
Number of employees in the market as a whole
Information about Impact BioMedical Inc (IBO) is limited, which may indicate an early stage of development. Biomedical startups typically create jobs for scientists and researchers. Their growth is driven by venture capital funding and scientific breakthroughs, rather than by general economic trends, as seen in the chart.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Impact BioMedical Inc (IBO)
Impact BioMedical is an early-stage biotech company. At such companies, value is almost 100% comprised of expectations and intellectual property. This chart shows the "optional" value the market places on their scientific concepts and patents per (likely very few) employee.
%20of%20the%20company%20Impact%20BioMedical%20Inc%20(IBO)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Impact-BioMedical-Inc-IBO&v=1772587109355 "Chart of market capitalization per employee (in thousands of dollars) of the company Impact BioMedical Inc (IBO)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
Impact BioMedical (IBO) is an early-stage biopharmaceutical company. For such companies, this metric is a purely speculative assessment of their scientific ideas. Any value on this chart reflects investors' belief that a small team of scientists can turn their concept into a working drug that will transform medicine.
%20by%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-other&v=1772587109372 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma other")
Market capitalization per employee (in thousands of dollars) for the overall market
Impact BioMedical is an early-stage pharmaceutical development company. Its current valuation is speculative. This metric reflects investors' faith in the company's scientific concept and team. The market cap here is an option for future success, not a reflection of current operating performance or headcount.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772587109420 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Impact BioMedical Inc (IBO)
Impact BioMedical is an early-stage development company focused on creating new pharmaceuticals. For such companies, this graph almost always shows a negative value. This reflects that every employee represents an R&D investment, and the company is in the process of "burning" capital to develop its assets.
%20Chart%20Impact%20BioMedical%20Inc%20(IBO)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Impact-BioMedical-Inc-IBO&v=1772587109458 "Company Profit Per Employee (in thousands of dollars) Chart Impact BioMedical Inc (IBO)")
Profit per employee (in thousands of dollars) in the market segment - Pharma other
Impact BioMedical Inc. is a biopharmaceutical company developing new therapeutics. Efficacy in this industry often remains hidden in the laboratory until commercialization. This chart reflects the current financial return per team, allowing us to assess operational burden and potential as developments progress toward market.
%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-other&v=1772587109474 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma other")
Profit per employee (in thousands of dollars) for the market as a whole
Impact BioMedical is likely an early-stage biotech company. Like other R&D startups, their business is not about generating profits, but rather investing in research and clinical trials. This chart, which shows the average personnel efficiency across the economy, highlights the uniqueness of the biotech sector, where capital is burned per scientist.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772587109481 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Impact BioMedical Inc (IBO)
Impact BioMedical, as a biomedical company, is likely in the research phase. A lack of revenue per employee at this stage is normal. The timeline is important for assessing the future: the commercialization of even one product or technology can lead to a sharp increase in this metric, reflecting the value of the intellectual property created.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Impact-BioMedical-Inc-IBO&v=1772587109493 "Sales chart per company employee Impact BioMedical Inc (IBO)")
Sales per employee in the market segment - Pharma other
Impact BioMedical is a research-stage biotechnology company focused on developing therapies for various diseases, including oncology. They have no commercial revenue. This chart, showing the average burn rate in the sector, serves as a benchmark for IBO's R&D staffing efficiency compared to competitors.
Sales per employee for the market as a whole
Impact BioMedical is an early-stage biotech company focused on developing new therapeutics. Currently, the company has no commercial revenue, and all its activities are conducted in the laboratory. This chart reflects its status as an R&D startup investing in future discoveries.
Short shares by company, segment and market as a whole
Shares shorted by company Impact BioMedical Inc (IBO)
Impact BioMedical (IBO) is another early-stage biomedical company. This chart tracks short positions. Without a clear breakthrough product, shorting such companies often reflects a bet that the company is merely a shell or that its science isn't strong enough to ever lead to a commercial product.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Impact-BioMedical-Inc-IBO&v=1772587109696 "Short Shares Chart for the Company Impact BioMedical Inc (IBO)")
Shares shorted by market segment - Pharma other
Impact BioMedical (IBO) is likely an early-stage company. This chart, which represents short positions in the biotech sector as a whole, reflects investors' high skepticism about the risks of clinical trials and the difficulty of financing companies without approved products.
Shares shorted by the overall market
Impact BioMedical (IBO) is a clinical-stage biotech company. Its value reflects its hope for future success. When this indicator of overall pessimism rises, investors are less inclined to hope. They are dumping unprofitable companies en masse that require refinancing.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Impact BioMedical Inc (IBO)
Impact BioMedical (IBO) is a company developing a wide range of therapeutics, from antivirals to cancer treatments. This broad focus brings both opportunities and risks. This indicator measures the strength of speculative moves. It shows when the stock is "overheated" (above 70) on news about one of its candidates or "oversold" (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Impact-BioMedical-Inc-IBO&v=1772587109899 "RSI 14 indicator chart for the company's stock Impact BioMedical Inc (IBO)")
RSI 14 Market Segment - Pharma other
Impact BioMedical is an early-stage biotech company developing drugs for a variety of diseases, potentially including oncology and inflammatory conditions. This chart shows the overall sentiment in the specialty pharmaceutical sector. It helps us understand whether IBO's momentum is driven by its unique technology or is a general "wave" across the industry.
RSI 14 for the overall market
Impact BioMedical (IBO) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast IBO (Impact BioMedical Inc)
Impact BioMedical is a preclinical-stage biotech company developing new therapeutics. This chart shows the highly speculative average target price from analysts, which reflects not so much the company's current business but rather their assessment of the company's public shell and future R&D plans.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-IBO-Impact-BioMedical-Inc&v=1772587110088 "A chart showing analyst consensus forecasts for the expected stock price. IBO (Impact BioMedical Inc)")
The difference between the consensus estimate and the actual stock price IBO (Impact BioMedical Inc)
Impact BioMedical is an early-stage R&D company developing a pipeline of drug candidates. This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and forecast, reflecting their "venture capital" assessment of the company's research portfolio and the risks associated with preclinical research.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-IBO-Impact-BioMedical-Inc&v=1772587110166 "A chart showing the difference between the consensus forecast and the actual stock price. IBO (Impact BioMedical Inc)")
Analyst consensus forecast for stock prices by market segment - Pharma other
Impact BioMedical (IBO) is a company developing pharmaceuticals, likely in the early or preclinical stage. This chart shows analysts' overall expectations for the entire pharmaceutical sector. It reflects whether experts believe in new R&D breakthroughs or anticipate a "winter" in biotech funding.
Analysts' consensus forecast for the overall market share price
Impact BioMedical is an early-stage biotech company exploring various areas, including oncology and antivirals. This chart reflects the overall market "risk appetite." For Impact, a company with a broad but fuzzy focus, overall market optimism (risk appetite) is critical to raising the capital needed for research.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Impact BioMedical Inc
Impact BioMedical is likely an early-stage biotech R&D company, perhaps in oncology or immunology. It's a binary risk business: all or nothing. This chart is a pure indicator of faith in their R&D. It doesn't reflect current sales (they don't have any), but rather a speculative assessment of their scientific progress, clinical trial data, and chances of approval.
AKIMA Market Segment Index - Pharma other
Impact BioMedical (IBO) is a biopharmaceutical company developing drugs to treat cancer and infectious diseases. They often employ a strategy of repurposing or improving existing molecules. This chart shows the average index for the segment. It helps investors assess how this R&D strategy compares to the average risk in the pharmaceutical industry.
The AKIM Index for the overall market
Impact BioMedical is a holding company investing in a portfolio of health and wellness technologies. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this diversified micro-cap stock compares to the overall economic situation.
